echoloc

Cepheid Tech Stack

Molecular diagnostics platform automating PCR testing across clinical settings

Biotechnology Research Sunnyvale, CA 5,001–10,000 employees Founded 1996 Public Company

Cepheid operates a portfolio of molecular diagnostic systems (GeneXpert and Xpert tests) spanning infectious disease, oncology, and genetic testing. The company is mid-migration to SAP S/4HANA while maintaining heavy infrastructure-as-code tooling (Terraform, CloudFormation, Ansible, Chef, Puppet) and CI/CD across AWS and Azure — typical of a regulated medical-device firm scaling ops and compliance automation. Active hiring skews toward engineering and senior roles, with projects focused on next-generation instrument firmware, diagnostic software, and cross-functional data-to-application workflows.

Tech Stack 146 technologies

Core StackSalesforce Terraform CloudFormation Ansible GitLab CI/CD Jenkins Azure DevOps Puppet AWS SAP SAP S/4HANA Java JavaScript AWS CodePipeline Chef Git Fiori SAP Access Control SAP GRC Process Control Excel Word PowerPoint Outlook SAP Fiori SAP BTP SAP RISE SAP Cloud ALM Adobe Experience Manager OSGi HTL+115 more
AdoptingSAP S/4HANA

What Cepheid Is Building

Challenges

  • New product development
  • Ensuring compliance with global regulations
  • Maintaining audit-ready records
  • Improving product reliability
  • Improving existing system designs and processes
  • Ensuring firmware regulatory compliance
  • Denied claims
  • Audit compliance
  • Boost assay utilization
  • Ensuring system reliability

Active Projects

  • Molecular diagnostics application software
  • Global sap transformation projects
  • Genxpert software product development
  • Global clinical marketing strategy
  • Next-generation diagnostic devices firmware
  • Operational tools for productivity
  • Next generation medical diagnostic instrument platforms
  • Cross-functional collaboration to deliver high-performance, user-centric solutions bridging data engineering and application development
  • Continuous improvement of software engineering processes
  • Design verification ecosystem for instrument firmware

Hiring Activity

Steady180 roles · 70 in 30d

Department

Engineering
46
Sales
21
Healthcare
17
Quality
14
Ops
12
Manufacturing
9
Research
9
Support
9

Seniority

Senior
84
Mid
27
Staff
21
Lead
13
Director
12
Manager
5
Principal
4
Junior
3

Notable leadership hires: Facilities Director, Market Access Director, Marketing Director, Director Product Management

Company intelligence

Find more companies like Cepheid by tech stack, pain points and active projects

Get started free

About Cepheid

Cepheid is a public diagnostic-instruments company (part of Danaher) headquartered in Sunnyvale, California, with 5,001–10,000 employees. The company manufactures and distributes GeneXpert automated PCR systems and a broad Xpert test portfolio covering respiratory infections, TB, blood virology, women's health, oncology, and genetic testing — products used in central labs, hospitals, and near-patient settings. Operations span multiple countries: the United States, India, Sweden, South Africa, Malaysia, Singapore, Portugal, Spain, Malawi, and Saudi Arabia. Core challenges center on new-product development, firmware and system regulatory compliance, product reliability, and claims processing.

HeadquartersSunnyvale, CA
Company Size5,001–10,000 employees
Founded1996
Hiring MarketsMalawi, Sweden, United States, India, South Africa, Malaysia, Singapore, Portugal

Frequently Asked Questions

What is Cepheid's tech stack?

Cepheid uses Salesforce for CRM, SAP (including S/4HANA, Fiori, BTP, and GRC) for enterprise resource planning, AWS and Azure for cloud infrastructure, Terraform and CloudFormation for infrastructure-as-code, and GitLab CI/CD, Jenkins, and Azure DevOps for deployment pipelines.

What countries is Cepheid hiring in?

Cepheid actively recruits across ten countries: United States, India, Sweden, South Africa, Malaysia, Singapore, Portugal, Spain, Malawi, and Saudi Arabia.

Similar Companies in Biotechnology Research

Other companies in the same industry, closest in size